Retinal Vein Occlusion Market Size
Market Size in USD Bn
CAGR5.9%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 5.9% |
| Market Concentration | High |
| Major Players | Roche, Regeneron Pharmaceuticals, AbbVie, Novartis, Kodiak Sciences Inc and Among Others |
please let us know !
Retinal Vein Occlusion Market Analysis
The Retinal Vein Occlusion Market is estimated to be valued at USD 2.40 billion in 2025 and is expected to reach USD 3.58 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. The primary factors driving market growth are the rising geriatric population which is more susceptible to retinal diseases and increase in ophthalmic disease prevalence globally.
The Retinal Vein Occlusion market is expected to witness positive growth over the forecast period due to increasing research activities for development of novel drugs for treatment of retinal vein occlusion. Additionally, growth opportunities in emerging markets and rise in healthcare expenditure are further expected to supplement the market growth through 2032.